Annual Congress Amsterdam 2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

Material from 2011 Show

Oral Presentation
Chairs: B. Robinson (Perth, Australia), A. Scherpereel (Lille, France)

Keynote lecture: Introduction: Treatment options and tumour biology of malignant pleural mesothelioma B. Robinson (Perth, Australia)
Antitumor activity of MEK and PI3K inhibitors in malignant pleural mesothelioma S. Miyoshi, H. Hamada, N. Hamaguchi, H. Katayama, K. Irifune, R. Ito, T. Miyazaki, J. Higaki (Toon, Hiroshima, Japan)
mTOR inhibition blocks tumor growth and pleural fluid accumulation in experimental murine mesothelioma M. Vazakidou, S. Magouta, C. Moschos, M. Stratiki, C. Roussos, I. Kalomenidis (Athens, Greece)
Epigenetic deregulated translation control of C/EBP-alpha leads to increased mesothelioma cell proliferation J. Zhong, N. Miglino, M. Tamm, D. Lardinois, L. Bubendorf, J. Szilard, M. Roth (Basel, Switzerland; Sydney, Australia)
The regulatory effect of microRNAs on STAT signaling in malignant mesothelioma L. Arzt, H. Kothmaier, F. Quehenberger, I. Halbwedl, H. H. Popper (Graz, Austria)
Epithelial-to-mesenchymal transition in malignant mesothelioma A. Diaz-Baquero, B. Romero Romero, L. Gomez-Izquierdo, R. Avila Polo, J. Martin-Juan, F. Rodriguez-Panadero (Seville, Spain)
Multimodality treatment of malignant pleural mesothelioma G. Ak, M. Metintas, H. Yildirim, H. Batirel, C. Sivrikoz, G. Sari, E. Doner, S. Metintas, E. Dundar (Eskisehir, Istanbul, Turkey)